A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro

Journal of Neurochemistry

Volumn 120, Issue 4, 2012, Pages 631-640

  Savelkoul, Paul J M ^a   Janickova, Helena ^b   Kuipers, Almar A M ^a   Hageman, Robert J J ^a   Kamphuis, Patrick J ^a,c   Dolezal, Vladimir ^b   Broersen, Laus M ^a  

^a DANONE RESEARCH   (Netherlands)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Alzheimer's disease; docosahexaenoic acid; G protein coupled receptors; muscarinic receptor; PC12; uridine

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; G PROTEIN COUPLED RECEPTOR; ICOSAPENTAENOIC ACID; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; PHOSPHOLIPID; PYRIDOXINE; SELENIUM; URIDINE PHOSPHATE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; FEMALE; IN VITRO STUDY; MEMBRANE BINDING; MEMORY DISORDER; MONOTHERAPY; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; NUTRIENT CONTENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR AFFINITY; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ANIMALS; CARBACHOL; CHO CELLS; CRICETINAE; CRICETULUS; GTP-BINDING PROTEINS; HUMANS; MEMBRANE POTENTIALS; MICRONUTRIENTS; PC12 CELLS; PROTEIN BINDING; RATS; RECEPTOR, MUSCARINIC M1; UP-REGULATION;

CRICETULUS GRISEUS;

EID: 84855963869     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07616.x     Document Type: Article

References (56)

1. Alemany R., Perona J. S., Sanchez-Dominguez J. M., Montero E., Canizares J., Bressani R., Escriba P. V., and, Ruiz-Gutierrez V., (2007) G protein-coupled receptor systems and their lipid environment in health disorders during aging. Biochim. Biophys. Acta-biomembr. 1768, 964-975. (Pubitemid 46454396)
2. Alexander S. P. H., Mathie A., and, Peters J. A., (2009) Guide to Receptors and Channels (GRAC), 4th edition (2009). Br. J. Pharmacol. 158, S1-S254.
3. Baxter D. F., Kirk M., Garcia A. F., et al. (2002) A novel membrane potential-sensitive fluorescent dye improves cell-based assays for ion channels. J. Biomol. Screen. 7, 79-85. (Pubitemid 34208865)
4. Berkeley J. L., and, Levey A. I., (2000) Muscarinic activation of mitogen-activated protein kinase in PC12 cells. J. Neurochem. 75, 487-493. (Pubitemid 30485429)
5. Bonner T. I., (1989a) The molecular basis of muscarinic receptor diversity. Trends Neurosci. 12, 148-151. (Pubitemid 19072592)
6. Bonner T. I., (1989b) New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. Dec (Suppl.), 11-15. (Pubitemid 20004454)
7. Bonner T. I., Buckley N. J., Young A. C., and, Brann M. R., (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237, 527-532. (Pubitemid 17125922)
8. Bonner T. I., Young A. C., Brann M. R., and, Buckley N. J., (1988) Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes. Neuron 1, 403-410.
9. Brown D. A., and, Passmore G. M., (2009) Neural KCNQ (Kv7) channels. Br. J. Pharmacol. 156, 1185-1195.
10. Brown D. A., Hughes S. A., Marsh S. J., and, Tinker A., (2007) Regulation of M(Kv7.2/7.3) channels in neurons by PIP2 and products of PIP2 hydrolysis: significance for receptor-mediated inhibition. J. Physiol. 582, 917-925. (Pubitemid 47104328)
11. Buckley N. J., Bonner T. I., Buckley C. M., and, Brann M. R., (1989) Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35, 469-476. (Pubitemid 19114964)
12. Buxbaum J. D., Oishi M., Chen H. I., Pinkas-Kramarski R., Jaffe E. A., Gandy S. E., and, Greengard P., (1992) Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor. Proc. Natl Acad. Sci. USA 89, 10075-10078.
13. Caccamo A., Oddo S., Billings L. M., Green K. N., Martinez-Coria H., Fisher A., and, LaFerla F. M., (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671-682. (Pubitemid 43290127)
14. Cansev M., and, Wurtman R. J., (2007) Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 148, 421-431. (Pubitemid 47364815)
15. Cansev M., Wurtman R. J., Sakamoto T., and, Ulus I. H., (2008) Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimer's Dementia 4, S153-S168.
16. Clancy S. M., Boyer S. B., and, Slesinger P. A., (2007) Coregulation of natively expressed pertussis toxin-sensitive muscarinic receptors with G-protein-activated potassium channels. J. Neurosci. 27, 6388-6399. (Pubitemid 46920365)
17. Davis A. A., Fritz J. J., Wess J., Lah J. J., and, Levey A. I., (2010) Deletion of m1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo. J. Neurosci. 30, 4190-4196.
18. Eltze M., Gönne S., Riedel R., Schlotke B., Schudt C., and, Simon W. A., (1985) Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug. Eur. J. Pharmacol. 112, 211-224. (Pubitemid 15038025)
19. Fredriksson R., and, Schioth H. B., (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol. Pharmacol. 67, 1414-1425. (Pubitemid 40594140)
20. Grossfield A., Feller S. E., and, Pitman M. C., (2006) A role for direct interactions in the modulation of rhodopsin by ω-3 polyunsaturated lipids. Proc. Natl Acad. Sci. USA 103, 4888-4893.
21. Holguin S., Huang Y., Liu J., and, Wurtman R., (2008a) Chronic administration of DHA and UMP improves the impaired memory of environmentally impoverished rats. Behav. Brain Res. 191, 11-16.
22. Holguin S., Martinez J., Chow C., and, Wurtman R., (2008b) Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 22, 3938-3946.
23. Jakubik J., El-Fakahany E. E., and, Dolezal V., (2006) Differences in kinetics of xanomeline binding and selectivity of activation of g proteins at M1 and M2 muscarinic acetylcholine receptors. Mol. Pharmacol. 70, 656-666. (Pubitemid 44092326)
24. Jakubik J., Randakova A., El-Fakahany E., and, Dolezal V., (2009) Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors. BMC Pharmacol. 9, 15.
25. Jones S. V., (1993) Muscarinic receptor subtypes: modulation of ion channels. Life Sci. 52, 457-464.
26. Jones C. K., Brady A. E., Davis A. A., et al. (2008) Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats. J. Neurosci. 28, 10422-10433.
27. Jope R. S., Song L., and, Powers R. E., (1997) Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain. Neurobiol. Aging, 18 111-120. (Pubitemid 27062193)
28. Joseph J. A., Cutler R., and, Roth G. S., (1993) Changes in G Protein-mediated Signal Transduction in Aging and Alzheimer's Disease. Ann. N Y Acad. Sci. 695, 42-45. (Pubitemid 23348233)
29. Kelly J. F., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M., Roth G. S., and, Mattson M. P., (1996) Amyloid beta-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Natl Acad. Sci. USA 93, 6753-6758.
30. Kennedy E. P., and, Weiss S. B., (1956) The function of cytidine coenzymes in the biosynthesis of phospholipides. J. Biol. Chem. 222, 193-214.
31. Lee N. H., and, Malek R. L., (1998) Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity. J. Biol. Chem. 273, 22317-22325. (Pubitemid 28399791)
32. Levey A., Kitt C., Simonds W., Price D., and, Brann M., (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11, 3218-3226.
33. Machova E., Jakubik J., Michal P., Oksman M., Iivonen H., Tanila H., and, Dolezal V., (2008) Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice. Neurobiol. Aging 29, 368-378. (Pubitemid 351215591)
34. Machova E., Rudajev V., Smyckova H., Koivisto H., Tanila H., and, Dolezal V., (2010) Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice. Neurobiol. Dis. 38, 27-35.
35. van Meer G., Voelker D. R., and, Feigenson G. W., (2008) Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112-124. (Pubitemid 351158912)
36. Michal P., Rudajev V., El-Fakahany E. E., and, Dolezal V., (2009) Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways. Eur. J. Pharmacol. 606, 50-60.
37. Nitsch R. M., Slack B. E., Wurtman R. J., and, Growdon J. H., (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
38. Niu S.-L., Mitchell D. C., Lim S.-Y., Wen Z.-M., Kim H.-Y., Salem N., and, Litman B. J., (2004) Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to n-3 fatty acid deficiency. J. Biol. Chem. 279, 31098-31104. (Pubitemid 39037771)
39. Peralta E. G., Ashkenazi A., Winslow J. W., Smith D. H., Ramachandran J., and, Capon D. J., (1987) Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6, 3923-3929.
40. Peralta E. G., Winslow J. W., Ashkenazi A., Smith D. H., Ramachandran J., and, Capon D. J., (1988) Structural basis of muscarinic acetylcholine receptor subtype diversity. Trends Pharmacol. Sci. Feb (Suppl.), 6-11.
41. Pooler A. M., Guez D. H., Benedictus R., and, Wurtman R. J., (2005) Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells. Neuroscience 134, 207-214. (Pubitemid 40943647)
42. Prasad R., Paila Y. D., Jafurulla M., and, Chattopadhyay A., (2009) Membrane cholesterol depletion from live cells enhances the function of human serotonin(1A) receptors. Biochem. Biophys. Res. Commun. 389, 333-337.
43. Rajagopal S., Rajagopal K., and, Lefkowitz R. J., (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373-386.
44. Richardson U. I., and, Wurtman R. J., (2007) Polyunsaturated fatty acids stimulate phosphatidylcholine synthesis in PC12 cells. Biochim. Biophys. Acta (BBA), Mol. Cell Biol. Lipids 1771, 558-563. (Pubitemid 46518278)
45. Rosenbaum D. M., Rasmussen S. G. F., and, Kobilka B. K., (2009) The structure and function of G-protein-coupled receptors. Nature 459, 356-363.
46. Scheltens P., Kamphuis P. J., Verhey F. R., Olde Rikkert M. G., Wurtman R. J., Wilkinson D., Twisk J. W., and, Kurz A., (2010) Efficacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement. 6, 1-10; e11.
47. Teather L. A., and, Wurtman R. J., (2006) Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats. J. Nutr. 136, 2834-2837. (Pubitemid 44771782)
48. Thathiah A., and, De Strooper B., (2009) G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci. Signal. 2, re8.
49. Tsang S. W., Lai M. K., Kirvell S., Francis P. T., Esiri M. M., Hope T., Chen C. P., and, Wong P. T., (2006) Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol. Aging 27, 1216-1223. (Pubitemid 44088578)
50. Wang L., Albrecht M. A., and, Wurtman R. J., (2007) Dietary supplementation with uridine-5'-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat. Brain Res. 1133, 42-48. (Pubitemid 46123254)
51. Wettschureck N., and, Offermanns S., (2005) Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159-1204. (Pubitemid 41362268)
52. Whiteaker K. L., Gopalakrishnan S. M., Groebe D., Shieh C. C., Warrior U., Burns D. J., Coghlan M. J., Scott V. E., and, Gopalakrishnan M., (2001) Validation of FLIPR membrane potential dye for high throughput screening of potassium channel modulators. J. Biomol. Screen. 6, 305-312. (Pubitemid 33027497)
53. de Wilde M. C., Penke B., van der Beek E. M., Kuipers A. A., Kamphuis P. J., and, Broersen L. M., (2011) Neuroprotective effects of a specific multi-nutrient intervention against abeta42-induced toxicity in rats. J. Alzheimers Dis. 27, 327-339.
54. Wurtman R. J., Ulus I. H., Cansev M., Watkins C. J., Wang L., and, Marzloff G., (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res. 1088, 83-92. (Pubitemid 43729416)
55. Wurtman R. J., Cansev M., Sakamoto T., and, Ulus I. H., (2009) Use of phosphatide precursors to promote synaptogenesis. Annu. Rev. Nutr. 29, 6.1-6.29.
56. Yeo E.-J., and, Park S. C., (2002) Age-dependent agonist-specific dysregulation of membrane-mediated signal transduction: emergence of the gate theory of aging. Mech. Ageing Dev. 123, 1563-1578. (Pubitemid 35449220)